| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/10/2007 | CN100341889C Antigen epitope II of B cell of chicken IBDV VP3 protein |
| 10/10/2007 | CN100341824C Animal and plant high effect ecological nutritive liquid and its preparation method |
| 10/10/2007 | CN100341579C Method for preparing gene therapeutic tissue engineering stent |
| 10/10/2007 | CN100341575C Water soluble dry compositions |
| 10/10/2007 | CN100341573C Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 10/10/2007 | CN100341572C Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 10/10/2007 | CN100341569C Compound protease medicine for treating prostate proliferation and its preparing method |
| 10/10/2007 | CN100341568C Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents |
| 10/10/2007 | CN100341567C Compositions for nasal administration of insulin |
| 10/10/2007 | CN100341566C Use of cone shell polypeptide derivative in preparation of drug abstaining medicine |
| 10/10/2007 | CN100341565C New use of prophymosin-alpha |
| 10/10/2007 | CN100341518C Use of sulfated glycosaminoglycans for establishing effective labor in women |
| 10/10/2007 | CN100341494C Eye wrinkle-removing film patch |
| 10/10/2007 | CN100341428C Nutritional composition preventing bacterial overgrowth |
| 10/09/2007 | US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
| 10/09/2007 | US7279573 Benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 10/09/2007 | US7279568 Highly efficient eukaryotic expression vector comprising an exogenous transcription regulatory element |
| 10/09/2007 | US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response |
| 10/09/2007 | US7279566 Antisense nucleotide sequences for use in reducing cell division associated with cell proliferative, skin and autoimmune disorders; RNA interference and microtuble formation |
| 10/09/2007 | US7279560 Administering monoclonal antibodies to inhibit transmission of costimulatory signal of lymphocytes; antiallergens; autoimmune diseases |
| 10/09/2007 | US7279559 Antibody which immunologically reacts with an interleukin 22 protein |
| 10/09/2007 | US7279558 The protein encoded by novel gene has two WW domains that participate in protein interactions in the N-terminal domain, and this protein binds to other proteins, thus regulates the intracellular signal transduction, gene expression |
| 10/09/2007 | US7279557 Therapeutic and diagnostic agents |
| 10/09/2007 | US7279552 Pro1782 polypeptides |
| 10/09/2007 | US7279550 For therapy of immune or autoimmune diseases |
| 10/09/2007 | US7279549 Apha-conotoxin peptides |
| 10/09/2007 | US7279502 Such as prostate cancer, prostatitis and benign prostatic hyperplasia; ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane |
| 10/09/2007 | US7279485 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 10/09/2007 | US7279464 For immunizing a mammal against cancer cells that present a carcinoembryonic antigen (CEA) |
| 10/09/2007 | US7279461 Screening for a material that promotes or inhibits binding between a rabconnectin-3-binding protein having a specific amino acid sequence and rabconnectin-3 and therefore would be useful for regulating Ca2+-dependent exocytosis |
| 10/09/2007 | US7279459 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis |
| 10/09/2007 | US7279458 Glycopeptide group is covalently linked to a pyridinium moiety of a cephalosporin group; reacting a glycopeptide containing (c6.c6.c6.c6.c6.c10n2.c13n2o.c13n2o ring) with a cephalosporin or salt in presence of a diacid |
| 10/09/2007 | US7279457 Stability and rapid onset of action; may be administered via buccal administration, sublingual administration, pulmonary delivery, nasal administration, subcutaneous administration, rectal administration, vaginal administration, or ocular administration |
| 10/09/2007 | US7279329 Expression system for producing collagen |
| 10/09/2007 | US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif |
| 10/09/2007 | US7279317 Modulation of COP9 signalsome isopeptidase activity |
| 10/09/2007 | US7279309 Process for manufacture of Nematode-extracted Anticoagulant Protein (NAP) |
| 10/09/2007 | US7279307 Determining the risk of metastasis of a breast or colon tumor, which involve determining whether a tissue sample from a tumor expresses a polypeptide encoded by a gene SEQ ID NOS:1-18 |
| 10/09/2007 | US7279305 Gene, disrupted in schizophrenia |
| 10/09/2007 | US7279300 Protozoan rhomboid proteins |
| 10/09/2007 | US7279291 Polypeptides having a triggering NK activity and biological applications |
| 10/09/2007 | US7279289 Bioassay of measuring tyrosine-kinase ligand, tumor necrosis factor and transforming growth factor level, before administering the myelosuppressive agent to the patient; use in optimizing treatment and avoiding toxic effects |
| 10/09/2007 | US7279282 Methods for identifying a candidate for treatment of obesity |
| 10/09/2007 | US7279172 Treatment of autoimmune conditions with copolymer 1 and related copolymers |
| 10/09/2007 | US7279169 A diphtheria toxoid, a tetanus toxoid, and a detoxified pertussis holotoxin; and a detoxified E. coli heat labile toxin that is is LT-K63 or LT-R72; is administered intranasally |
| 10/09/2007 | US7279168 Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof |
| 10/09/2007 | US7279166 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| 10/09/2007 | US7279159 Nucleic acids; fusion proteins; binding to endothelial growth factor; fusion polypeptides capable of binding vascular endothelial cell growth factor (VEGF), VEGF family members, and splice variants with specifically desirable characteristics; therapy for ocular diseases |
| 10/09/2007 | US7279158 Methods for the treatment of inflammatory joint disease |
| 10/09/2007 | US7279157 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease |
| 10/09/2007 | US7279155 Inhibiting receptor of a cytokine-2 member of the interleukin-1 family as antiinflammatory agent; sepsis, liver,brain, or lung injuries; arthritis, psoriasis, inflammatory bowel disease |
| 10/09/2007 | US7279149 Amino acid composition with increased blood brain barrier permeability |
| 10/09/2007 | US7278843 Methods for fine powder formation |
| 10/09/2007 | US7278419 Method for treating diabetes mellitus in a patient |
| 10/09/2007 | CA2455012C Enteral compositions for the prevention and/or treatment of sepsis |
| 10/09/2007 | CA2396174C Aerothricin analogs, their preparation and use |
| 10/09/2007 | CA2253393C Dispersible macromolecule compositions and methods for their preparation and use |
| 10/09/2007 | CA2197062C Drug delivery composition containing chitosan or derivative thereof having a defined z. potential |
| 10/09/2007 | CA2158544C Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 10/09/2007 | CA2156416C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 10/09/2007 | CA2099503C Synthetic alpha-l-iduronidase and genetic sequences encoding same |
| 10/05/2007 | CA2646021A1 O-glycans in the treatment of inflammatory bowel disease and cancers |
| 10/04/2007 | WO2007112453A2 Methods amd compositions for treating conditions |
| 10/04/2007 | WO2007112451A2 Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents |
| 10/04/2007 | WO2007112364A1 Methods for treating kidney disorders |
| 10/04/2007 | WO2007112357A2 Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders |
| 10/04/2007 | WO2007112352A2 Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders |
| 10/04/2007 | WO2007112348A2 Prodrug composition |
| 10/04/2007 | WO2007112345A2 Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders |
| 10/04/2007 | WO2007112045A2 Use of somatostatin agonists to treat medullary thyroid carcinoma |
| 10/04/2007 | WO2007112039A2 Methods and compositions for modulating t cell and/or b cell activation |
| 10/04/2007 | WO2007112026A2 Localized delivery of a therapeutic agent by barbed staples |
| 10/04/2007 | WO2007112024A2 Barbed sutures having a therapeutics agent thereon |
| 10/04/2007 | WO2007111969A2 C-reactive protein apheresis |
| 10/04/2007 | WO2007111535A1 Immunomodulating composition |
| 10/04/2007 | WO2007111496A1 Improved carbohydrate recognition domains |
| 10/04/2007 | WO2007111350A1 Agent for inhibition of angiogenesis or mesenchymal-type or amoeboid-type invasion of cancer cell |
| 10/04/2007 | WO2007111275A1 Method for inhibiting signal transduction, signal transduction inhibitor to be used therein and use thereof |
| 10/04/2007 | WO2007110811A2 Use of the staudinger ligation in in vivo assembly of a biologically active compound |
| 10/04/2007 | WO2007110783A2 Method of manufacturing fibrous hemostatic bandages |
| 10/04/2007 | WO2007110772A1 Immunomodulating oligopeptides |
| 10/04/2007 | WO2007110297A1 Healthy food product |
| 10/04/2007 | WO2007110296A1 Healthy food product |
| 10/04/2007 | WO2007110098A1 HBx PEPTIDES, CAPABLE OF ELICITING A PROMISCUOUS IMMUNODOMINANT CD4+ RESPONSE DIRECTED AGAINST HBV |
| 10/04/2007 | WO2007109908A1 Therapeutic yb-1 phosphorylation decoys |
| 10/04/2007 | WO2007109857A1 Agent for the treatment of hormone-dependent disorders and uses thereof |
| 10/04/2007 | WO2007109825A1 Method for treating stage iv melanoma |
| 10/04/2007 | WO2007109823A2 Peptide library |
| 10/04/2007 | WO2007109821A1 Pharmaceutical preparation for the prevention of infections |
| 10/04/2007 | WO2007092645A3 Novel hcv inhibitor combinations and methods |
| 10/04/2007 | WO2007092616A3 Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto |
| 10/04/2007 | WO2007085238A3 Multifunctional mixture of active substances |
| 10/04/2007 | WO2007075343A3 Enzymes for reduced immunological stress |
| 10/04/2007 | WO2007070899A3 Pharmaceutical composition for treating haemorrhagic shock and its consecutive symptoms |
| 10/04/2007 | WO2007070390A3 Method for prolonging activity of autodegradable enzymes |
| 10/04/2007 | WO2007067964B1 Mucosal delivery of stabilized formulations of exendin |
| 10/04/2007 | WO2007066179A3 Peptides for antagonisation of anticoagulants and uses thereof |
| 10/04/2007 | WO2007059342A3 Random copolymer compositions for treating unwanted immune response |
| 10/04/2007 | WO2007047995A3 Modified proteases that inhibit complement activation |
| 10/04/2007 | WO2007047205A3 Enzyme inhibitors of pai-1 |